(Q48625167)

13 February 2018

title

Adalimumab for juvenile idiopathic arthritis-associated uveitis. (English)

1 reference

13 February 2018

juvenile rheumatoid arthritis

0 references

1 reference

1 reference

Adriano Magli

1

0 references

author name string

Raimondo Forte

2

1 reference

13 February 2018

Pasqualina Navarro

3

1 reference

13 February 2018

Giustina Russo

4

1 reference

13 February 2018

Francesca Orlando

5

1 reference

13 February 2018

Loredana Latanza

6

1 reference

13 February 2018

Maria Alessio

7

1 reference

13 February 2018

publication date

1 March 2013

1 reference

13 February 2018

Graefe's Archive for Clinical and Experimental Ophthalmology

published in

1 reference

13 February 2018

volume

251

1 reference

13 February 2018

issue

6

1 reference

13 February 2018

page(s)

1601-1606

1 reference

13 February 2018

https://scigraph.springernature.com/pub.10.1007/s00417-013-2275-x

exact match

0 references

cites work

Juvenile arthritis and uveitis

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Recent advances in uveitis of juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Biologic agents for the treatment of juvenile rheumatoid arthritis: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

New advances in the management of juvenile idiopathic arthritis--2: the era of biologicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Retrospective case review of pediatric patients with uveitis treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

High dose infliximab in the treatment of refractory uveitis: does dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Adalimumab in the therapy of uveitis in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Long-term efficacy of adalimumab in the treatment of uveitis associated with juvenile idiopathic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Lensectomy for complicated cataract in juvenile chronic iridocyclitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00417-013-2275-X

Preliminary definition of improvement in juvenile arthritis

21 January 2018

1 reference

12 December 2020

Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) is the main predictor of severe course uveitis

1 reference

12 December 2020

Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997

1 reference

12 December 2020

Adalimumab therapy for childhood uveitis

1 reference

12 December 2020

Favorable response to high-dose infliximab for refractory childhood uveitis

1 reference

12 December 2020

Aqueous Humor and Serum Tumor Necrosis Factor-α in Clinical Uveitis

1 reference

12 December 2020

Prognostic factors in the uveitis of juvenile rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.

1 reference

12 December 2020

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

1 reference

12 December 2020

Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis

1 reference

12 December 2020

Dismantling the pyramid

1 reference

12 December 2020

Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status.

1 reference

12 December 2020

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

1 reference

12 December 2020

10.1007/S00417-013-2275-X

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018